P ulmonary arterial hypertension (PAH) is a disease characterized by a progressive loss and obliteration of distal pulmonary arteries (PAs) that result in elevation of PA pressure, increased pulmonary vascular resistance to flow, right-sided heart failure, and high morbidity as well as mortality. Developing effective treatments for PAH will require an approach that reverses the fundamental mechanisms causing the pulmonary vascular pathology.
P ulmonary arterial hypertension (PAH) is a disease characterized by a progressive loss and obliteration of distal pulmonary arteries (PAs) that result in elevation of PA pressure, increased pulmonary vascular resistance to flow, right-sided heart failure, and high morbidity as well as mortality. Developing effective treatments for PAH will require an approach that reverses the fundamental mechanisms causing the pulmonary vascular pathology.
Mutations resulting in loss of function of bone morphogenetic protein receptor 2 (BMPR2) occur in >70% of patients with familial PAH (FPAH) and in 25% of those with idiopathic PAH (IPAH), collectively denoted as hereditary PAH (HPAH). 1, 2 Reduced expression of BMPR2 was shown in patients with IPAH without a mutation and even when PAH was related to other conditions (associated PAH [APAH]). 3 There is a low 20% penetrance of PAH in families carrying a BMPR2 mutation that has been partially addressed by recent genetic studies, indicating that affected versus unaffected family members have reduced expression of BMPR2 from the normal allele 4 or polymorphisms causing heightened transforming growth factor β (TGFβ)-1 signaling. 5 Other studies documented a reduction in the BMPR2 ligand, BMP4 (bone morphogenetic protein 4). 6 We have reported compensatory signaling pathways and gene expression in the unaffected BMPR2 mutation carriers. 7 Elastic fibers provide elastic recoil to tissues such as the large arteries, lung, and skin. They consist of 2 major morphologically distinct components: elastin, a cross-linked polymer of tropoelastin, the monomeric secreted form of the protein, 8 and fibrillins, primarily fibrillin-1, a large (350 kDa), cysteine-rich glycoprotein. 9 Fibrillin microfibrils are the pivotal structures involved in storage and regulation of growth factors of the TGFβ superfamily, including TGFβ1 and BMPs. 10, 11 Although the role of TGFβ signaling in the formation of elastic fibers in arteries and in other tissues is well known, 12 the contribution of BMPs to this process has not been studied.
Previous reports by our group have shown degradation of elastic fibers as a prominent feature of PAH, related to elevation in PA elastase activity identified as neutrophil elastase. 13 This enzyme is pivotal to vascular pathobiology because it releases mitogenic growth factors that are normally bound to intact elastic fibers and other matrix components. 14 Degradation products of elastin, elastin peptides, are highly proinflammatory, 15 promoting the recruitment of activated inflammatory cells that produce cytokines and elastase that perpetuate adverse vascular remodeling. Mutations in the ELN gene (elastin) are associated with vascular disorders causing stenosis of pulmonary and systemic arteries in Willliams syndrome, 16 whereas mutations in the FBN1 gene (fibrillin-1) cause aneurysmal dilatation in Marfan syndrome. 17 Given the physical association of BMPs and TGFβ with fibrillin-1, we hypothesized that these growth factors could play a complementary role in the organization and stability of the elastic fiber. Our study uncovered a codependence between BMPR2 and TGFβ in the assembly of the elastic fiber. TGFβ-stimulated production of the elastin protein was BMPR2 dependent, as was BMP-and TGFβ-mediated production of fibrillin-1. Hence, elastic fiber assembly was impaired in IPAH vascular cells, particularly in those cells from patients with HPAH and a BMPR2 mutation. In transgenic mice with compound heterozygosity for Bmpr2/1a, that develop more severe pulmonary hypertension than wild-type mice, we show production of a fibrillin-1 poor elastic fiber that is susceptible to elastase-mediated degradation. This is consistent with more advanced pathological features noted in HPAH patients with a BMPR2 mutation 18 that have more rapid progression of disease.
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Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
TGFβ1 Increases Elastin mRNA and Protein; TGFβ1 and BMP4 Increase Fibrillin-1 Protein
To investigate the relative roles of TGFβ1 and BMP4 signaling in the assembly of elastic fibers, we used human PA adventitial fibroblasts (PAF) and PA smooth muscle cells (SMCs) at passages 3 to 6 cultured from donor control lungs from the Pulmonary Hypertension Breakthrough Initiative (see Table 1 , and Materials and Methods in the online-only Data Supplement). We found that TGFβ1 substantially increased ELN mRNA in PAF at 4 and 8 hours after stimulation ( Figure 1A ) and elastin protein assessed at 48 hours ( Figure 1B ). Although BMP4 alone did not increase elastin mRNA or protein, it enhanced production of elastin protein when added to TGFβ1 ( Figure 1B ). Neither TGFβ1 nor BMP4 increased FBN1 mRNA levels in PAF ( Figure 1C ). However, BMP4 and TGFβ1 increased fibrillin-1 protein in PAF-conditioned media ( Figure 1D ). There was, however, no further increase when the 2 were administered together. BMP4 was chosen as the ligand that best produced fibrillin-1 following pilot studies that also assessed BMP2 and BMP7 (data not shown). We could not account for the BMP4-mediated increase in fibrillin-1 that accumulated in the conditioned media on the basis of an increase in fibronectin previously described 20 ( Figure IA in the online-only Data Supplement). We also investigated whether BMP4-mediated transcription of other elastin assembly proteins could promote accumulation of fibrillin-1 but saw no significant elevation in mRNA for emilin-1, lysyl oxidase, fibulin-5, and microfibrillar associated glycoprotein 1 or 2 ( Figure IB in the online-only Data Supplement). PAF were then stimulated with BMP4, TGFβ1, or both every other day for 7 days to generate elastic fibers. We used both elastin ( Figure 1E ) and fibrillin-1 ( Figure 1F ) antibodies and applied quantitative morphometric techniques to images obtained by confocal microscopy to measure linear elastic immunoreactive fibers. Despite the fact that BMP4 did not increase elastin protein, we saw similar elastin immunoreactivity in the fibers when compared with TGFβ1. There was also an enhanced effect when the 2 were administered together. As with the biochemical data, BMP4 and TGFβ each resulted in fibrillin immunoreactivity in the deposited fibers but combining the 2 agents did not result in a further increase in fibrillin. This suggested that BMP4 made efficient use of constitutive elastin to assemble elastic fibers.
In PA SMC as in PAF, we observed an increase in elastin mRNA ( Figure IIA Figure 1 . Transforming growth factor-β1 (TGFβ1) increases elastin mRNA and protein and TGFβ1 and BMP4 increase extracellular fibrillin-1 in human pulmonary artery fibroblasts. Human pulmonary artery fibroblasts (PAF) isolated from unused donor lungs and used between passages 3 and 6 were stimulated with BMP4 (10 ng/mL), TGFβ1 (2 ng/mL), BMP4+TGFβ1, or vehicle (Con). A and C, Fold change in mRNA of ELN and FBN1 was measured 4 and 8 h after stimulation. B and D, Representative immunoblots above and densitometry below for elastin in cell lysates and fibrillin-1 in conditioned media 48 h after stimulation. β-Actin and Ponceau staining were used as loading controls for cell lysates and conditioned media, respectively. Fibrillin-1 is normalized to Con. Bars represent mean±SEM of n=3 to 5 independent experiments, *P<0.05, **P<0.01, ***P<0.001 vs Con, by 1-way ANOVA and post hoc Bonferroni test. E and F, PAF of donor controls were seeded in glass chamber slides and grown for 4 d to confluence. Cells were starved overnight, then stimulated every other day for 7 d with vehicle (Con), BMP4, TGFβ1, or BMP4+TGFβ1. Elastic fibers were visualized by indirect immunofluorescence of elastin (E) and fibrillin-1 (F). Right, fluorescence intensities quantified by Image J software and normalized to cell number assessed by nuclei DAPI (4',6-diamidino-2-phenylindole) staining. Bar=100 μm. Bars represent mean±SEM of n=4 independent experiments. **P<0.01; ****P<0.0001 vs Con; ###P<0.001; ####P<0.0001 vs BMP4; &&&&P<0.0001 vs TGFβ1, by 2-way ANOVA and post hoc Bonferroni test.
microscopy. To determine whether PA SMCs were secreting a factor that interfered with elastic fiber assembly, we cultured PA SMC in fibroblast-conditioned media and PAF in PA SMCconditioned media ( Figure IIIA and IIIB in the online-only Data Supplement). In keeping with our hypothesis, PA SMC assembled elastic fibers in response to BMP4 or TGFβ1 when cultured in PAF-conditioned media, whereas PAF cultured in PA SMCconditioned media only produced scant elastic fibers in response to TGFβ1. We then applied 2-dimensional gel electrophoresis as described in the Materials and Methods in the online-only Data Supplement to identify a secreted factor that suppressed elastic fiber assembly in PA SMC-conditioned media that was not present in PAF-conditioned media ( Figure IIIC in the online-only Data Supplement). Of the proteins differentially produced, the proteoglycan decorin ( Figure IIID in the onlineonly Data Supplement) was known to suppress elastic fiber assembly, 21 and it was reduced in the PAF relative to PA SMCconditioned media at baseline and with BMP4 or TGFβ1 stimulation. We then reduced decorin in PA SMC by siRNA and showed production of dense elastic fibers ( Figure IIIE in the online-only Data Supplement), and we also added decorin to PAF-conditioned media and suppressed elastic fiber formation ( Figure IIIF in the online-only Data Supplement).
TGFβ1 Production of Elastin Is BMPR2 Dependent
To determine the role of BMPR2 in PAF production of elastin and fibrillin-1, we reduced BMPR2 by >60% using siRNA ( Figure 2A ). Interestingly, we found that TGFβ1 production of elastin protein ( Figure 2A ) was greatly reduced as was BMP4 and TGFβ1 production of fibrillin-1 ( Figure 2B ). Neither the BMPR2-dependent increase in elastin in response to TGFβ1, nor the BMP4-mediated increase in fibrillin-1 could be explained by changes in downstream effectors pSMAD1/5 or p-p38, or in microRNAs previously implicated downstream of BMPR2 such as miR21 or miR29 22, 23 (data not shown). Surprisingly, the TGFβ1 increase in elastin mRNA was preserved despite the loss of BMPR2 ( Figure IV in the onlineonly Data Supplement). This implied that BMPR2 may be necessary for TGFβ1-mediated translation of elastin mRNA or stability of the elastin protein. Loss of fibrillin-1 by siRNA did not interfere with elastin protein production in response to TGFβ1 (Figure 2A ).
Nontargeting (control) siRNA did not affect the linear deposition of elastic fibers in response to BMP4 or TGFβ1 ( Figure 1C ). As expected, the elastic fiber network produced after BMP4 stimulation was lost when BMPR2 was reduced by siRNA. Although quantitatively the elastic fibers produced in response to TGFβ1 were not reduced with loss of BMPR2, Figure 2 . Bone morphogenetic protein receptor 2 (BMPR2) and fibrillin-1 are required for pulmonary artery adventitial fibroblast (PAF) elastic fiber formation. PAF of donor controls were transfected with siRNA oligonucleotides targeting BMPR2 or FBN1, or with nontargeting siRNA (siControl). Starting 24 h after transfection, the cells were stimulated for 48 h with BMP4 (10 ng/mL), TGFβ1 (2 ng/mL), or vehicle (Control). A and B, Representative immunoblot above and densitometry below for elastin and BMPR2 in cell lysates (A) and fibrillin-1 in conditioned media (B) of PAF donor controls. β-Actin and Ponceau were used as loading controls for cell lysates and conditioned media, respectively. C, To assess elastic fibers, cells were stimulated every other day for 7 d and then visualized by indirect immunofluorescence of elastin and quantified by Image J software. Note that reduction of BMPR2 and fibrillin-1 inhibited BMP4-induced elastic fiber formation and reduced fibrillin-1 also inhibited TGFβ1-induced fiber formation. The elastic fibers induced by TGFβ1 appear more fragmented in cells treated with BMPR2 siRNA. Bar=100 µm. Bars represent mean±SEM of n=3 independent experiments, *P<0.05; ***P<0.001 vs unstimulated Control; ##P<0.01; ###P<0.001 vs nontargeting siRNA (siControl) by 2-way ANOVA and post hoc Bonferroni test.
they were more fragmented. This implies that the modest production of fibrillin and elastin in response to TGFβ1 was sufficient to allow for deposition of elastic fibers that were structurally abnormal. However, experiments with fibrillin siRNA indicated that both TGFβ1 and BMP4 require fibrillin-1 to deposit and assemble elastic fibers.
Fibroblasts From PAH Patients Have Impaired Elastic Fiber Assembly
To investigate the consequence of BMPR2 dysfunction on elastic fiber formation in PAH, we compared PAF from unused donor lungs to PAF from lungs of patients with IPAH and from those with a BMPR2 mutation related to HPAH (see Table 2 Figure 3. Reduced pulmonary artery adventitial fibroblast (PAF) elastic fibers from idiopathic pulmonary arterial hypertension (IPAH) and hereditary pulmonary arterial hypertension (HPAH) with BMPR2 mutation (BMPR2m) related to elastin and fibrillin-1. Elastic fiber formation by PAF was analyzed as described in Figure 1 . Fold change in ELN and FBN1 mRNA (A and C) measured 4 and 8 h after stimulation by BMP4 (10 ng/mL), TGFβ1 (2 ng/mL), or vehicle Control. Representative immunoblot and densitometry for elastin in the cell lysates and fibrillin-1 in the conditioned media (B and D) measured 48 h after stimulation. E, Elastic fibers were visualized by indirect immunofluorescence of elastin and quantified by Image J software. Bar=100 µm. β-Actin and Ponceau were used as loading controls. Bars represent mean±SEM of n=3 different cell lines (donor controls) per condition, *P<0.05; **P<0.001; ***P<0.001 vs unstimulated (Control); #P<0.05; ##P<0.01; ###P<0.001 vs donor, by 2-way ANOVA and post hoc Bonferroni test.
for patient characteristics). There was a profound decrease in ELN mRNA at baseline with no or minimal response to BMP4 or TGFβ1 in IPAH patients including the group with a BMPR2 mutation ( Figure 3A) . TGFβ1-stimulated an increase in elastin protein in donor control and a more variable increase IPAH PAF, but there was a barely detectable increase in elastin protein in BMPR2 mutant cells ( Figure 3B) . In PAF from patients with IPAH and in BMPR2 mutant cells, there was a profound reduction in FBN1 mRNA ( Figure 3C ) that resulted in reduced fibrillin-1 protein in conditioned media in response to TGFβ1or BMP4 ( Figure 3D ). Thus, in IPAH PAF, elastic fiber formation was greatly impaired in response to both BMP4 and TGFβ1, and in cells from the BMPR2 mutant group, it was barely detectable ( Figure 3E ). This is consistent with the loss of fibrillin-1 ( Figure V in the online-only Data Supplement) and elastin protein in the latter group.
To relate our findings in cultured PAF to the tissue, we determined whether elastin and fibrillin-1 are also reduced in PAs of PAH patients. Immunofluorescence revealed reduced fibrillin-1 in IPAH PAs, particularly in the internal elastic lamina, and a loss of both elastin and fibrillin-1 in PAs in lungs from patients with HPAH and a BMPR2 mutation (Figure 4 ). We hypothesized that mice with impaired function of BMPR2 would have poorly assembled elastic fibers that were susceptible to degradation. To test this, mice with compound heterozygosity for Bmpr2 and 1a (Bmpr2/1a) were used. We pooled 3 groups of central PAs from 4 mice/pool and documented a marked decrease in fibrillin-1 protein without a comparable reduction in elastin in the compound heterozygotes compared with wild-type (WT) mice ( Figure 5A ). Aortae exhibited a similar abnormality (data not shown).
Bmpr2/1a
We then evaluated whether the fibrillin-1-poor elastic fibers in those PAs from Bmpr2/1a heterozygotes relative to WT mice were susceptible to degradation. As in our previous studies, 13 we perfused the vessels with either porcine pancreatic elastase or saline vehicle and counted the number and size of fenestrations in the autofluorescent internal elastic lamina of the main PA by confocal microscopy. Both the area and number of fenestrations were increased 2-fold in the Bmpr2/1a heterozygote versus WT elastic lamina after perfusion with elastase ( Figure 5B ). We also determined whether a pathological insult resulting in pulmonary hypertension in association with an increase in lung elastase activity 24 would result in greater degradation of elastin in Bmpr2/1 heterozygote versus WT mice. After administration of the VEGF (vascular endothelial growth factor) receptor blocker Sugen 5416 by subcutaneous injection once a week during a 3-week period of hypoxia (10% oxygen), 25 we observed more pronounced degradation of PA elastic fibers in the Bmpr2/1 heterozygote versus WT mice ( Figure 5B ).
We determined whether the susceptibility of elastic fibers to degradation could be related to more severe pulmonary hypertension in the Bmpr2/1a versus control mice. A decrease in pulmonary artery acceleration time in Bmpr2/1a heterozygotes when compared with WT controls ( Figure 5C ) was associated with a small but significant increase in right ventricular systolic pressure ( Figure 5D ) and with more severe right ventricular hypertrophy ( Figure 5E ) after Sugen and hypoxia.
Immunofluorescence of elastin and fibrillin-1 in intrapulmonary arteries assessed at the level of the terminal respiratory unit showed fragmentation of elastic fibers in association with pulmonary hypertension, which was more severe in the Bmpr2/1a heterozygotes versus WT mice ( Figure 5F and 5G). This was associated with a greater loss of alveolar wall and duct arteries relative to alveoli ( Figure 5H ). Muscularization of distal vessels was similar ( Figure VI in the online-only Data Supplement).
Discussion
Although previous studies have focused on the antagonistic effects of BMPs and TGFβ in PAH, 5 our work indicates that, as in development, 26 both growth factors that co-occupy the same extracellular matrix protein, fibrillin-1, 11,27 take part in assembling elastic fibers. In this article, we show a previously unappreciated dependence of both TGFβ1 and BMP4 on BMPR2 in the assembly of the 2 main components of the elastic fiber, elastin and fibrillin-1 ( Figure 6 ). Neither the dependence on BMPR2 of TGFβ1-mediated production of elastin and fibrillin nor the regulation of fibrillin-1 accumulation by BMPs had been previously established. In IPAH and HPAH BMPR2 mutant PAF, the profound reduction in ELN and FBN1 mRNA is related to the impaired production of elastic fibers. The reduction in PA fibrillin-1 in Bmpr2/1a heterozygote mice is associated with susceptibility of the elastic fibers to degradation, with more fragmented elastin, a greater loss of distal arteries, and more severe pulmonary hypertension in response to VEGF receptor blockade and chronic hypoxia.
Elastic laminae are an integral component of the PA and are fragmented in PAs of PAH patients in association with occlusive changes. Breakdown of elastic laminae is observed with neointimal formation that occurs with age 28 and with vascular inflammation, 29 and yet little attention has been paid to whether the underlying composition of the elastic fibers might increase susceptibility to degradation. It is not surprising that TGFβ1 stimulated an increase in elastin mRNA and protein in both PA SMC and PAF, based on previous studies. 30 It had also been shown that TGFβ stimulates production of fibrillin-1, 31 although this was not studied in vascular cells.
Previous models of elastic fiber formation in culture used epithelial cells, dermal fibroblasts, or rat smooth muscle cells. [32] [33] [34] [35] For the present study, we developed a cell culture system that is robust in assessing factors that contribute to assembly of the elastic fibers in the vessel wall. Our studies revealed the importance of fibrillin-1 production for the formation of stable elastic fibers in culture. It is known that TGFβ1 stimulates elastin synthesis by a mechanism involving stabilization of the mRNA. 36 Loss of BMPR2 function likely Figure 6 . Model of elastic fiber formation in control, idiopathic pulmonary arterial hypertension (IPAH), and hereditary pulmonary arterial hypertension (HPAH) with a bone morphogenetic protein receptor 2 (BMPR2) mutation. Although transforming growth factor-β1 (TGFβ1) stimulates elastin mRNA, production of elastin and fibrillin-1 proteins are both largely BMPR2 dependent. TGFβ1 and BMP4 via BMPR2 increase fibrillin-1. In IPAH, the elastic fiber formation is impaired because of reduced fibrillin-1 mRNA and protein and elastin mRNA, although some elastin protein is produced in response to TGFβ1. When there is a mutation in BMPR2, fibrillin-1 and elastin protein are both markedly decreased in response to both TGFβ1 and BMP4, leading to poorly assembled elastic fibers. impairs the stability of the elastin protein because the TGFβ1-mediated increase in elastin mRNA is preserved. The reduction in elastin protein may be related to metabolic changes associated with loss of BMPR2 37 that could perturb post-translational modifications necessary for elastin protein stability. This and the mechanism that explains the profound reduction in ELN and FBN1 mRNA in PAH cells will be of interest to pursue in future studies. Despite the failure of TGFβ1 to increase ELN mRNA in IPAH PAF, elastin protein was still increased. In BMPR2 mutant PAF, TGFβ could not increase elastin protein. Impaired stimulation of fibrillin-1 protein by both BMP4 and TGFβ1 may be largely related to the low mRNA levels in IPAH and BMPR2 mutant HPAH PAF. This is reflected in fibrillin-poor PAs in the tissue sections of IPAH patients. The reduction in elastin production in response to TGFβ1 that was prominent in PAH cells with a BMPR2 mutation is reflected in the more profound loss of elastin in elastic fibers in the PAs from these patients.
We found that the elastic fibers in the PAs of Bmpr2/1a compound heterozygote compared with WT mice are more susceptible to degradation by exogenous administration of elastase. It is the endogenous lung elastase associated with exposure to Sugen 5416 and chronic hypoxia 24 that resulted in elastic fiber degradation in the PAs of both Hemodynamic data from catheterization was obtained from studies performed closest to transplantation. PAH medications are listed according to total drug exposure during treatment period of patient, not necessarily in combination. EF is fiber formation in culture. Patients with familial pulmonary arterial hypertension classified separately because they were mutant for BMPR2 (Bmpr2m). PAP is measured in mm Hg. In PAP, s means systolic, d means diastolic, and m means mean. BMPR2 indicates bone morphogenetic protein receptor 2; HPAH, hereditary pulmonary arterial hypertension; IF, immunofluorescence; IPAH, idiopathic pulmonary arterial hypertension; 6MW, distance (m) walked in 6 min; N/A, not available; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance (dynes/sec•cm −5 ) (baseline fick PVR); qPCR, quantitative polymerase chain reaction; and WB, Western immunoblot.
genotypes. However, the enhanced susceptibility to degradation observed in the Bmpr2/1a compound heterozygote compared with WT mice can be ascribed to the decrease in fibrillin-1. It was unexpected to find no reduction in elastin protein in the PAs of the Bmpr2/1a compound heterozygote compared with WT mice despite the fact that TGFβ1 is dependent on BMPR2 to produce elastic fibers. Perhaps reproducing this dependency in the mice requires greater deficiency of BMPR2 than haploinsufficiency, as was achieved with BMPR2 siRNA, or as is observed in the PAH subgroup with a BMPR2 mutation.
Despite the loss of fibrillin-1 and susceptibility of the elastic fiber to degradation, we did not see the aneurysmal dilatation observed when there is a mutation in FBN1, as in Marfan syndrome. 38 Recently, SMC apoptosis has been described in transgenic mice with a mutation in FBN1, 39 and loss of BMPR2 signaling by reduced BMPR2 can lead to resistance to apoptosis in SMC. 40 Bmpr2 heterozygous mice have no 41 or little 42 resting elevation of pulmonary arterial pressure under normal conditions or even with hypoxia alone. 41 We reasoned that compound heterozygosity might bring out a more consistent increase in hypoxia-induced pulmonary hypertension, but it was necessary to use an additional stimulus, that is, VEGF receptor blockade. It is interesting that the pathological features associated with the more severe pulmonary hypertension related to a greater loss of distal arteries rather than to increased muscularization, but we anticipate that this feature, along with a greater increase in right ventricular systolic pressure and right ventricular hypertrophy, may progress over time.
Although heightened activity of TGFβ has been previously related to reduced activity of BMPR2 in pulmonary hypertension, 43, 44 our study shows a codependence between BMPR2 and TGFβ1 in assembling the key components of the elastic fiber. This reinforces the need for strategies that evaluate therapies for their ability to restore a balance between TGFβ and BMPR2 signaling.
